Carbon Makes Available FP3D Resin for Dental Labs

Carbon reports the launch of FP3D, a flexible, removable partial denture (FRPD) resin. The new material is a dental resin that incorporates Carbon’s dual-cure chemistry. Carbon says its it designed to deliver durability, translucency, dimensional accuracy, and flexibility, while offering lifelike aesthetics, and potential cost savings over other methods.

FP3D is the result of a multi-year development collaborative effort with Keystone Industries, driven by feedback from dental labs seeking a printable alternative to traditional methods. The result is an FDA-cleared Class II medical device designed to deliver durability, flexibility and strength, Carbon reports.

At the core of FP3D’s performance is Carbon’s dual-cure chemistry, previously validated in high-performance applications such as protective sports equipment, high-performance footwear midsoles, and customized bike saddles.

Key Benefits of FP3D Include:

• Safety—FP3D was cleared for removable partial dentures manufacturing by the FDA .
• Optimized Flexibility and Strength* – Flexural modulus of 800 MPa, strength and flexibility, engineered for comfortable fit and structural integrity.
• Durability* – Validated by 20,000+ fatigue cycles, flexible partial dentures printed with FP3D resin withstands repeated stress surpassing a 3-year lifetime.
• Dimensional Stability in Oral Conditions – Low water sorption (1.82 μg/mm³) aids resistance to swelling or deformation in moist environments.
• Natural Aesthetics and Polishability – High translucency and improved polishability deliver lifelike appearance and ease of finishing. 
• Workflow Integration – Designed for easy integration with existing digital dentures workflows, including Carbon’s AO polishing cassette.

*data available upon request

“FP3D sets a new standard for what digital dentures can achieve, and is already making an impact in dental labs,” comments Terri Capriolo, senior vice president of Oral Health, Carbon. “Initial feedback has been overwhelmingly positive—labs are particularly impressed by the material’s translucency, and the ease of integration with existing workflows. By introducing our dual-cure chemistry to dentistry, we’re helping labs to further streamline their operations, reduce costs, and deliver the next generation of flexible partials.”

FP3D is now commercially available in the United States and Canada. With FDA clearance secured, Carbon turns to the process for European regulatory approvals and expects to expand commercial availability across Europe in 2026.

Sources: Press materials received from the company and additional information gleaned from the company’s website.